Home > Healthcare > Medical Devices > Therapeutic Devices > Extracorporeal Membrane Oxygenation Market

Extracorporeal Membrane Oxygenation Market Share

Report ID: GMI2720
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Extracorporeal Membrane Oxygenation Market Share

The global extracorporeal membrane oxygenation market consists of several players including:

Abbott Laboratories
Fresenius Medical Care AG & Co
KGaA
Braile Biomedica
Edwards Lifesciences Corporation
Abiomed
Eurosets
Getinge AB
LivaNova PLC
Medtronic
MicroPort Scientific Corporation
Nipro
SB-Kawasumi Laboratories Inc
Spectrum Medical,
Terumo Corporation

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for ECMO stood at over USD 490 million in 2022 and is expanding consistently at more than 3% CAGR driven by the increasing prevalence of respiratory failure and cardiopulmonary diseases.

Extracorporeal cardiopulmonary resuscitation (ECPR) segment is expected to accumulate over 5% market share by 2032 owing to the increasing incidences of sudden cardiac arrests.

Ppediatric segment garnered over USD 100 million in 2022 driven by the increasing prevalence of several pediatric diseases, such as pneumonia, meconium aspiration syndrome, respiratory distress syndrome (RDS), and congenital diaphragmatic hernia (CDH).

North America amassed over 58% share of ECMO market in 2022 due to the increasing elderly populace and the considerable growth in healthcare expenditure across the region.